Lincoln Pharmaceuticals Ltd has accepted the resignation of Manoj Rai, Senior General Manager and Head of Quality Assurance (QA), with effect from September 24, 2026. Rai cited personal reasons for his departure from the senior management role.

The company informed stock exchanges in a regulatory filing that Rai’s resignation is effective after close of business hours on the specified date. The move was disclosed under Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation details

According to the filing, Rai submitted his resignation letter on June 13, 2026. In the letter, he stated his decision to pursue a new professional opportunity aligned with his long-term career aspirations. He expressed gratitude to the management and leadership team for the support extended during his tenure.

Rai indicated his readiness to serve the prescribed three-month notice period. However, he requested early relief by adjusting his available earned or privilege leave balance against a portion of the notice period, subject to organizational approval and requirements.

Regulatory disclosure

The company provided the required details under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The following table summarizes the key particulars disclosed:

The filing noted that the copy of the resignation letter was enclosed with the intimation. Trusha Kashish Shah, Company Secretary and Compliance Officer, signed the document digitally on September 24, 2026.

Lincoln Pharmaceuticals has scheduled its 32nd Annual General Meeting for September 30, 2026, to approve a final dividend of ₹1.80 per equity share for the fiscal year ended March 31, 2026. The payout represents an 18% dividend on the face value of ₹10 per share.

The meeting will be conducted via video conferencing or other audio-visual means in accordance with Ministry of Corporate Affairs circulars. The book closure period runs from September 12, 2026, to September 30, 2026, with shareholders holding shares as of September 11, 2026, eligible for the dividend if approved.

Key Resolutions

The agenda includes ordinary and special business items requiring shareholder consent:

• Re-appointment of Whole Time Directors Mr. Hashmukh I. Patel and Mr. Munjal Mahendrabhai Patel, who retire by rotation.
• Ratification of remuneration for Kiran J. Mehta & Co., Cost Accountants, at ₹2,50,000 per annum plus applicable taxes and out-of-pocket expenses for the audit of cost records for FY27.

Director Profiles

The notice provides details on the directors seeking re-appointment:

Mr. Munjal Mahendrabhai Patel is the son of Managing Director Mr. Mahendra G. Patel. He also serves as an Independent Director at Mamata Machinery Limited.

Voting and Logistics

Remote e-voting opens on September 26, 2026, at 9:00 am and closes on September 29, 2026, at 5:00 pm. Shareholders can participate through CDSL or NSDL depository platforms. The company has appointed Parikh Dave & Associates as the scrutinizer for the e-voting process.

Tax deduction at source (TDS) will apply to dividend payments. Resident shareholders without a valid PAN face a 20% withholding tax, while those with valid PANs are subject to a 10% rate. Non-resident shareholders must provide Tax Residency Certificates to avail benefits under double tax avoidance agreements.